The Valley Desk

NCT05118789 · Interventional trial

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Locally Advanced Solid Tumor, Metastatic Solid Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov